Challenges in designing antirheumatic drug trials
Goldsmith, C.H.
Journal of Rheumatology 18(11): 1643-1644
1991
ISSN/ISBN: 0315-162X PMID: 1787482 Document Number: 377574
Document emailed within 1 workday
Related Documents
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
French, J.A. 1993: Obstacles encountered in designing antiepileptic drug trials Epilepsy Research. Suppl 10: 81-89
Breithaupt, H. 1994: Drug-induced liver damage caused by antirheumatic drugs--antirheumatic therapy in pre-existing liver damage Zeitschrift für Rheumatologie 53(4): 250-254
Grimová, J.; Nĕmecek, O.; Rádek, O.; Volková, Z. 1974: Pharmacological properties of a combination of the antirheumatic drug Benetazone (trimetazone) and the analgesic drug dextropropoxyphene Ceskoslovenska Farmacie 23(1): 28-33
Grisot, M.; Van Der Velden, M.; Vassilakopoulou, P. 2011: Socio-technical challenges in designing a web-based communication platform Studies in Health Technology and Informatics 169: 68-72
Arneson, H.T.; Colton, R.S. 1987: Drug-drug interaction with the use of antirheumatic drugs Minnesota Medicine 70(10): 589; 592
Hamada, C. 2015: Statistical Viewpoints on Designing Investigator Initiated Clinical Trials Nihon Geka Gakkai Zasshi 116(3): 176-180
Kelly, J.A.; Spielberg, F.; McAuliffe, T.L. 2008: Defining, designing, implementing, and evaluating phase 4 HIV prevention effectiveness trials for vulnerable populations Journal of Acquired Immune Deficiency Syndromes 47 Suppl. 1: S28-S33
Guyant, P.; Corbel, V.; Guérin, P.J.; Lautissier, A.; Nosten, F.ço.; Boyer, S.éb.; Coosemans, M.; Dondorp, A.M.; Sinou, V.ér.; Yeung, S.; White, N. 2015: Past and new challenges for malaria control and elimination: the role of operational research for innovation in designing interventions Malaria Journal 14: 279
Buchanan, W.W.; Kean, W.F. 1987: Implications of antirheumatic drug therapy in elderly patients with osteoarthritis Journal of Rheumatology 14(Special Issue): 98-100
Zanasi, R.; Volonteri, G.; Castaldi, D. 1971: Clinical evaluation of the use in arthrosis of a drug with antirheumatic and anti-inflammatory action Minerva Medica 62(3): 174-178
Griem, P.; Takahashi, K.; Kalbacher, H.; Gleichmann, E. 1995: The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues Journal of Immunology 155(3): 1575-1587
Johnson, M.; Lajiness, M.; Maggiora, G. 1989: Molecular similarity: a basis for designing drug screening programs Progress in Clinical and Biological Research 291: 167-171
Wolfe, F.; Rehman, Q.; Lane, N.E.; Kremer, J. 2001: Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment Journal of Rheumatology 28(7): 1704-1711
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
de Zoysa, I.; Elias, C.J.; Bentley, M.E. 1998: Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention American Journal of Public Health 88(4): 571-575
Smit, J.; Middelkoop, K.; Myer, L.; Lindegger, G.; Swartz, L.; Seedat, S.; Tucker, T.; Wood, R.; Bekker, L.-G.; Stein, D.J. 2005: Socio-behaviour challenges to phase IIi HIV vaccine trials in Sub-Saharan Africa African Health Sciences 5(3): 198-206
Essack, Z.; Koen, J.; Barsdorf, N.; Slack, C.; Quayle, M.; Milford, C.; Lindegger, G.; Ranchod, C.; Mukuka, R. 2010: Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa Developing World Bioethics 10(1): 11-21
Stone, A.J.; Morisky, D.; Detels, R.; Braxton, H. 1989: Designing interventions to prevent HIV-1 infection by promoting use of condoms and spermicides among intravenous drug abusers and their sexual partners Aids Education and Prevention: Official Publication of the International Society for Aids Education 1(3): 171-183